Magic mushroom compound tested for chronic pain relief
NCT ID NCT05068791
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether psilocybin, the active ingredient in magic mushrooms, can help reduce pain, fatigue, and other symptoms in people with fibromyalgia. Researchers will enroll 30 women aged 25-65 who have had widespread pain for at least a year. The goal is to see if psilocybin treatment improves pain severity, functioning, and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA, PRIMARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UAB Beacon Tower
RECRUITINGBirmingham, Alabama, 35209, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.